ADAGE CAPITAL PARTNERS GP, L.L.C. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$15,309,000
+2595.2%
900,000
+260.0%
0.03%
+1550.0%
Q1 2020$568,000
-50.5%
250,0000.0%0.00%
-33.3%
Q4 2019$1,148,000
-76.3%
250,000
-80.0%
0.00%
-75.0%
Q3 2019$4,844,000
-33.1%
1,250,000
+4.2%
0.01%
-33.3%
Q2 2019$7,236,000
-53.0%
1,200,000
+4.3%
0.02%
-53.8%
Q1 2019$15,410,000
+84.1%
1,150,000
+27.8%
0.04%
+69.6%
Q4 2018$8,370,000
-7.2%
900,000
+38.9%
0.02%
+15.0%
Q3 2018$9,020,000
-17.3%
648,000
-6.1%
0.02%
-20.0%
Q2 2018$10,909,000
-20.6%
690,000
-13.8%
0.02%
-21.9%
Q1 2018$13,744,000
-51.8%
800,000
-38.5%
0.03%
-50.0%
Q4 2017$28,496,000
-71.4%
1,300,000
-46.6%
0.06%
-73.6%
Q3 2017$99,522,000
+32.5%
2,432,700
-2.5%
0.24%
+31.5%
Q2 2017$75,094,000
-19.8%
2,494,000
-3.7%
0.18%
-22.0%
Q1 2017$93,629,000
-1.7%
2,590,000
+36.3%
0.24%
-9.2%
Q4 2016$95,209,000
-14.6%
1,900,000
-10.6%
0.26%
-15.3%
Q3 2016$111,546,000
+14.0%
2,125,100
-10.2%
0.31%
+15.0%
Q2 2016$97,875,000
-7.3%
2,367,000
-9.0%
0.27%
-6.6%
Q1 2016$105,638,000
+9.5%
2,600,000
+11.8%
0.29%
+13.0%
Q4 2015$96,488,000
+135.3%
2,325,000
-12.8%
0.25%
+121.9%
Q3 2015$41,014,000
-15.9%
2,664,949
+35.7%
0.11%
-6.6%
Q2 2015$48,773,000
+32.3%
1,963,492
+21.7%
0.12%
+35.6%
Q1 2015$36,864,000
+48.4%
1,613,284
+75.4%
0.09%
+47.5%
Q4 2014$24,837,000
+323.5%
919,882
+84.0%
0.06%
+335.7%
Q3 2014$5,865,000
+331.6%
500,000
+472.1%
0.01%
+250.0%
Q2 2014$1,359,00087,4030.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q2 2020.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders